Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Biotech, Cancer Center Partner on T-Cell Research

A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system. . . . → Read More: Biotech, Cancer Center Partner on T-Cell Research

Report: Health System Not Ready for Alzheimer’s Therapies

A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease. . . . → Read More: Report: Health System Not Ready for Alzheimer’s Therapies

FDA Clears First Sensor-Pill and App System

The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System

FDA Sets Genetic Health Test Review Process

The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers. . . . → Read More: FDA Sets Genetic Health Test Review Process

Report – 126 Alzheimer’s Drugs in Clinical Trials

A foundation supporting research on new drugs to treat Alzheimer’s disease says clinical trials now underway are testing 126 potential therapies for the disorder. . . . → Read More: Report – 126 Alzheimer’s Drugs in Clinical Trials

Cancer Drug Price Rises Shown Unrelated to Competition

An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market. . . . → Read More: Cancer Drug Price Rises Shown Unrelated to Competition

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Biosimilars Seen Saving U.S. $54 Billion

An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years. . . . → Read More: Biosimilars Seen Saving U.S. $54 Billion

Guidelines Designed for CAR T-Cell Cancer Therapies

Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects. . . . → Read More: Guidelines Designed for CAR T-Cell Cancer Therapies

FDA Clears First Mobile App for Substance Abuse

A smartphone app designed to help treat substance abuse disorders received approval from the U.S. Food and Drug Administration. . . . → Read More: FDA Clears First Mobile App for Substance Abuse